Showing 1 - 2 results of 2 for search 'Hasumati Rahalkar', query time: 0.03s Refine Results
  1. 1
    Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines

    Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines by Hasumati Rahalkar, Hasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices

    Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices by Hasumati Rahalkar, Hasumati Rahalkar, Alan Sheppard, Sam Salek, Sam Salek

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: